Neurology Drugs

Carbonic anhydrase inhibitor

Multiple Sclerosis — Disease-Modifying Therapy

Anti-CD52 monoclonal antibody

Triptan (5-HT1B/1D agonist)

Thrombolytic

Dopamine Agonist / NMDA Antagonist (Anti-Parkinsonian)

Dopaminergic / Antiviral (Adamantane Derivative)

Potassium Channel Blocker (Neuromuscular Junction Facilitator)

Tricyclic Antidepressant / Neuropathic Pain Agent

Dopamine Agonist — Parkinson's Disease Rescue / Continuous Infusion

Dopamine Receptor Agonist (Non-ergot)

Antiplatelet

Analgesic + Antiemetic (Migraine Treatment)

Read-Through Agent (Premature Stop Codon Suppressor)

CGRP Receptor Antagonist (Gepant — Migraine Prevention)

Muscle Relaxant — GABA-B Agonist

Anticholinergic (antimuscarinic, antiparkinsonian)

Histamine Analogue — Vertigo / Ménière's Disease

Neuromuscular blocker (presynaptic)

Antiepileptic — SV2A Ligand (Focal Seizures)

Antiepileptics

Antiepileptic (cannabinoid)

THC + CBD oromucosal spray

Antiepileptic / Trigeminal neuralgia

Anti-epileptic

Multiple Sclerosis — Disease-Modifying Therapy

Antiepileptic — 1,5-Benzodiazepine

Benzodiazepine

Antiplatelet (P2Y12 Inhibitor)

Levodopa + benserazide

Antiparkinsonian (dopamine precursor + decarboxylase inhibitor)

Direct Oral Anticoagulant — Thrombin Inhibitor

Sleep Disorders

Corticosteroid

Benzodiazepine / Antiepileptic

Fumaric acid ester (immunomodulator)

Disease-Modifying Therapy — Relapsing-Remitting Multiple Sclerosis

Antiplatelet (phosphodiesterase inhibitor + adenosine reuptake inhibitor)

Fumaric acid ester (prodrug of monomethyl fumarate)

Acetylcholinesterase Inhibitor

Rare Neurological Disorders

Stroke Prevention

Neonatal Fc receptor (FcRn) blocker

Triptan (5-HT₁B/1D agonist)

COMT Inhibitor — Parkinson's Disease

Antisense oligonucleotide (TTR silencer)

Anti-CGRP monoclonal antibody (IV)

CGRP Receptor Monoclonal Antibody — Migraine Prevention

Antiepileptic (sodium channel blocker)

Antiepileptic — T-type Calcium Channel Blocker

Potassium channel blocker

Serotonergic antiseizure agent

Multiple Sclerosis — Disease-Modifying Therapy

Sphingosine-1-phosphate receptor modulator

Continuous SC levodopa/carbidopa

Phenytoin prodrug (anticonvulsant)

Anti-CGRP monoclonal antibody

5-HT1B/1D agonist (triptan)

Alpha-2-Delta Ligand — Neuropathic Pain / Epilepsy Adjunct

Acetylcholinesterase Inhibitor — Dementia

Anti-CGRP monoclonal antibody

Immunomodulator

Osmotic agent / ICP reduction

Antioxidant / synthetic ubiquinone analogue

Interferon (immunomodulator)

Disease-Modifying Therapy — MS (Interferon)

Antidote / Metabolic Agent

Antiepileptic — Sodium Channel Slow Inactivation Enhancer

Anticonvulsant (Sodium Channel Blocker)

Migraine

Antiepileptic

Antiepileptic — Second-Line Status Epilepticus

Levodopa + DDC inhibitor + COMT inhibitor

Dopamine Precursor / Decarboxylase Inhibitor

Osmotic Diuretic / ICP reduction

NMDA Receptor Antagonist — Dementia

NMDA receptor antagonist

5-HT1B/1D agonist (triptan)

Disease-Modifying Therapy — MS (Anti-VLA-4 Monoclonal Antibody)

Calcium Channel Blocker (neuroprotective)

Rare Neurological Disorders

Antisense oligonucleotide (SMN2 splicing modifier)

Multiple Sclerosis — Disease-Modifying Therapy

Anti-CD20 monoclonal antibody

Multiple Sclerosis — Disease-Modifying Therapy

Anti-CD20 monoclonal antibody

Nrf2 activator

COMT inhibitor (3rd generation)

Antimuscarinic (Parkinsonian)

Antiepileptic — Sodium Channel Blocker

Sphingosine-1-phosphate receptor modulator

Pegylated interferon beta (immunomodulator)

Antiepileptic — AMPA Receptor Antagonist

Antiepileptic (sodium channel blocker)

Nootropic / GABA derivative

Histamine H3 receptor inverse agonist

5-HT2 antagonist (antihistamine)

Sphingosine-1-phosphate receptor 1 modulator

Dopamine Agonist (D2/D3 Receptor)

Barbiturate-derived antiepileptic

Antimuscarinic

Beta-Blocker — Migraine Prophylaxis

Acetylcholinesterase Inhibitor — Myasthenia Gravis

Reversible cholinesterase inhibitor

MAO-B Inhibitor — Parkinson's Disease

Neuroprotective Agent — ALS/Motor Neurone Disease

CGRP receptor antagonist (gepant)

Direct Oral Anticoagulant — Factor Xa Inhibitor

Acetylcholinesterase Inhibitor — Dementia

Selective 5-HT1B/1D agonist (triptan)

Dopamine Agonist — Parkinson's Disease

Dopamine Agonist — Transdermal Patch (Parkinson's / RLS)

Neonatal Fc receptor (FcRn) antagonist

Triazole-derivative antiepileptic

Selective MAO-B inhibitor + glutamate modulation

Anti-IL-6 receptor monoclonal antibody

MAO-B Inhibitor — Parkinson's Disease

Selective MAO-B inhibitor

Sphingosine-1-phosphate receptor 1/5 modulator

GHB salt (CNS depressant)

Antiepileptic / Mood stabiliser

Dopamine-noradrenaline reuptake inhibitor

Antiepileptic (orphan)

Triptan (5-HT1 agonist) / Antimigraine

Triptan + NSAID combination

Stroke Thrombolysis

Pyrimidine synthesis inhibitor

VMAT2 Inhibitor — Hyperkinetic Movement Disorders

GABA reuptake inhibitor (antiepileptic)

Muscle Relaxant — Alpha-2 Agonist

COMT inhibitor

Anticonvulsant (Multiple Mechanisms)

Anticholinergic — Parkinson's Disease / Dystonia

Antimuscarinic

Anti-CD20 monoclonal antibody

Antiepileptic / mood stabiliser

Dissociative steroid

Antiepileptic — GABA Transaminase Inhibitor

C5 complement inhibitor (subcutaneous)

5-HT1B/1D Agonist (Triptan)

Antiepileptic — Multiple Mechanisms